The epidemiology of parkinsonism was systematically studied in details in Sofia, a city of 1,167,295 inhabitants. The critical date of the study was the 31st of December, 1983. During the period of 10 years from 1972 to 1982 the morbidity of parkinsonism was 165.85/100,000 inhabitants, with a slight excess of men over women (52.1:47.9%); the average age was 60 years. A vascular etiology of parkinsonism was considered in 44%, followed by degenerative (32.55%), postencephalitic (19%), traumatic (2.4 %), and toxic etiology (1.7%). The mixed clinical form of the syndrome was met most frequently (46.6 %), followed by predominantly the tremor form (35.45 %), predominantly the rigid form (16.8%) and the bradykinetic form (1.15%). There was a greater prevalence of the mild degree of severity of the disease (62.3%), followed by the marked degree (20.9%) and the moderate degree (16.8%). Parkinsonian patients in Bulgaria without exception receive medication and all other kinds of treatment free of charge.

Keywords:
Parkinsonism
This content is only available via PDF.
© 1986 S. Karger AG, Basel
1986
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.